Show simple item record

dc.contributor.authorSainsbury, Frank
dc.date.accessioned2021-12-20T05:57:10Z
dc.date.available2021-12-20T05:57:10Z
dc.date.issued2017
dc.identifier.issn2041-5990en_US
dc.identifier.doi10.4155/tde-2017-0098en_US
dc.identifier.urihttp://hdl.handle.net/10072/411086
dc.description.abstractViruses possess a rich array of functional nucleic acids and proteins. Genome size limitations and a lifestyle that requires surreptitious entry into cells, followed by rampant replication within them, have endowed viruses with a finely tuned capability to coordinate cellular components and processes. Our use of these features drives fundamental methodology in biotechnology. From exploiting the viral regulatory sequences that enable heterologous gene expression in all kingdoms of life, to the use of viral vectors to protect and deliver replicating nucleic acid therapeutics, virus-derived technologies have become commonplace. With increasing structural knowledge of different viruses comes an opportunity to co-opt nature's nanoscale delivery vehicle for small molecule and protein therapeutics. The research and development of virus-like nanoparticles (VLNPs) exploits the structural characteristics of virus capsids as bionanotechnology platforms with great potential in drug delivery and molecular imaging.en_US
dc.description.peerreviewedYesen_US
dc.languageEnglishen_US
dc.publisherFUTURE SCI LTDen_US
dc.relation.ispartofpagefrom1019en_US
dc.relation.ispartofpageto1022en_US
dc.relation.ispartofissue12en_US
dc.relation.ispartofjournalTherapeutic Deliveryen_US
dc.relation.ispartofvolume8en_US
dc.subject.fieldofresearchBiomedical engineeringen_US
dc.subject.fieldofresearchMedical biotechnologyen_US
dc.subject.fieldofresearchPharmacology and pharmaceutical sciencesen_US
dc.subject.fieldofresearchcode4003en_US
dc.subject.fieldofresearchcode3206en_US
dc.subject.fieldofresearchcode3214en_US
dc.subject.keywordsScience & Technologyen_US
dc.subject.keywordsLife Sciences & Biomedicineen_US
dc.subject.keywordsPharmacology & Pharmacyen_US
dc.subject.keywordsbioconjugationen_US
dc.subject.keywordscapsiden_US
dc.titleVirus-like nanoparticles: emerging tools for targeted cancer diagnostics and therapeutics (Editorial)en_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationSainsbury, F, Virus-like nanoparticles: emerging tools for targeted cancer diagnostics and therapeutics (Editorial), Therapeutic Delivery, 2017, 8 (12), pp. 1019-1022en_US
dc.date.updated2021-12-20T05:55:35Z
gro.hasfulltextNo Full Text
gro.griffith.authorSainsbury, Frank


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record